TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T50688	Glycoprotein IIb/IIIa receptor	D0GY5Z	Aspirin	Approved	2244	C9H8O4	180.16	CC(=O)OC1=CC=CC=C1C(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	D0Q5LF	BIO-1211	Phase 2	9961766	C36H48N6O9	708.8	CC1=CC=CC=C1NC(=O)NC2=CC=C(C=C2)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B05BSL	(5S,8S)-8-[(1H-Benzoimidazol-2-ylamino)-methyl]-3-[(S)-2-carboxy-2-(2,4,6-trimethyl-benzenesulfonylamino)-ethylcarbamoyl]-1-oxa-2,7-diaza-spiro[4.4]non-2-ene-7-carboxylic acid methyl ester	Investigative	44350450	C29H35N7O8S	641.7	CC1=CC(=C(C(=C1)C)S(=O)(=O)N[C@@H](CNC(=O)C2=NO[C@]3(C2)C[C@H](N(C3)C(=O)OC)CNC4=NC5=CC=CC=C5N4)C(=O)O)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0DCY6	2-[(4-Bromophenyl)sulfonylamino]-3-[6-(2-piperidin-4-ylethoxy)naphthalen-2-yl]propanoic acid;hydrochloride	Investigative	134137328	C26H30BrClN2O5S	597.9	C1CNCCC1CCOC2=CC3=C(C=C2)C=C(C=C3)CC(C(=O)O)NS(=O)(=O)C4=CC=C(C=C4)Br.Cl	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0DPQ5	[4-Acetyl-16-acetylamino-13-(2-carbamimidoyl-ethyl)-13-(2-guanidino-ethyl)-3,3-dimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid	Investigative	73354557	C25H42N10O8S2	674.8	CC(=O)[C@H]1C(SSC[C@H](C(=O)N[C@@](C(=O)NCC(=O)N[C@H](C(=O)N1)CC(=O)O)(CCC(=N)N)CCN=C(N)N)NC(=O)C)(C)C	IC50 = 82000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0M9PX	2-[(2,6-Dimethylbenzoyl)amino]-3-[4-[4-[(pyridin-2-ylamino)methyl]piperidin-1-yl]phenyl]propanoic acid	Investigative	24872646	C29H34N4O3	486.6	CC1=C(C(=CC=C1)C)C(=O)NC(CC2=CC=C(C=C2)N3CCC(CC3)CNC4=CC=CC=N4)C(=O)O	IC50 = 77700 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0NZ7L	(2S)-3-Oxo-4-methyl-7-[2-(phenylamino)ethylcarbamoyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2-acetic acid	Investigative	15516067	C21H24N4O4	396.4	CN1CC2=C(C=CC(=C2)C(=O)NCCNC3=CC=CC=C3)N[C@H](C1=O)CC(=O)O	Ki ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0OV1S	(3S)-3-[[2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(2R)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	15088299	C17H30N8O8	474.5	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](CO)C(=O)N	IC50 = 138000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0OWK3	Arg-Gly-Asp-Arg-Gly-Asp	Investigative	10032445	C24H42N12O11	674.7	C(C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N)CN=C(N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0PD4I	7-[2-(3-Carbamimidoyl-phenylamino)-acetylamino]-heptanoic acid	Investigative	10829524	C16H24N4O3	320.39	C1=CC(=CC(=C1)NCC(=O)NCCCCCCC(=O)O)C(=N)N	IC50 = 64000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0PUR8	CID 10458809	Investigative	10458809	C30H40N4O3	504.7	CN1CC(CC2=CC=CC=C21)C(CC3CCN(CC3)C(=O)CCC4=NC5=C(CCCN5)C=C4)CC(=O)O	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0Q8EU	3-{2-[(5-Carbamimidoyl-1H-indole-2-carbonyl)-amino]-2-methyl-propionylamino}-3-phenyl-propionic acid	Investigative	10788997	C23H25N5O4	435.5	CC(C)(C(=O)NC(CC(=O)O)C1=CC=CC=C1)NC(=O)C2=CC3=C(N2)C=CC(=C3)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0VU1P	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]-[(3-fluorophenyl)methyl]amino]acetate	Investigative	56660095	C29H33FN4O4	520.6	CCOC(=O)CN(CC1=CC(=CC=C1)F)C2=CC3=C(C=C2)N(CC(O3)(C)COC4=CC=C(C=C4)C(=N)N)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B0YA6I	7-[2-(4-Carbamimidoyl-phenylamino)-acetylamino]-heptanoic acid	Investigative	10663504	C16H24N4O3	320.39	C1=CC(=CC=C1C(=N)N)NCC(=O)NCCCCCCC(=O)O	IC50 = 67000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B10SCP	3-[4-(2-Guanidino-acetylamino)-phenylsulfanyl]-3-pyridin-3-yl-propionic acid	Investigative	44372954	C17H19N5O3S	373.4	C1=CC(=CN=C1)C(CC(=O)O)SC2=CC=C(C=C2)NC(=O)CN=C(N)N	IC50 = 81000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B19FGU	(3R)-4-[1-[3-(5,6,7,8-Tetrahydro-1,8-naphthyridin-2-yl)propanoyl]piperidin-4-yl]-3-(5,6,7,8-tetrahydroquinolin-3-yl)butanoic acid	Investigative	44396062	C29H38N4O3	490.6	C1CCC2=C(C1)C=C(C=N2)[C@H](CC3CCN(CC3)C(=O)CCC4=NC5=C(CCCN5)C=C4)CC(=O)O	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B1BG9D	3-[2-(2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-[1-carboxy-2-(4-hydroxy-phenyl)-ethyl]-succinamic acid	Investigative	44304655	C21H31N7O8	509.5	C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N)O	IC50 = 94000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B1BR9K	3-[2-(2-Guanidino-acetylamino)-phenylsulfanyl]-3-pyridin-3-yl-propionic acid	Investigative	44373300	C17H19N5O3S	373.4	C1=CC=C(C(=C1)NC(=O)CN=C(N)N)SC(CC(=O)O)C2=CN=CC=C2	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B1FEL6	(2S)-3-[[2-[(3R,5S)-1-(3,3-Dimethylbutanoyl)-5-[(pyridin-2-ylamino)methyl]pyrrolidin-3-yl]oxyacetyl]amino]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid	Investigative	11613998	C31H43N5O6	581.7	CC1=CC(=C(C(=C1)C)C(=O)N[C@@H](CNC(=O)CO[C@@H]2C[C@H](N(C2)C(=O)CC(C)(C)C)CNC3=CC=CC=N3)C(=O)O)C	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B1H8QO	2-[[2-[(4-Carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]-[(3,4-difluorophenyl)methyl]amino]acetic acid	Investigative	57403383	C27H28F2N4O4	510.5	CC1(CN(C2=C(O1)C=C(C=C2)N(CC3=CC(=C(C=C3)F)F)CC(=O)O)C)COC4=CC=C(C=C4)C(=N)N	IC50 = 80000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B1IDC0	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-6-yl]-[(3,5-difluorophenyl)methyl]amino]-2-oxoacetate	Investigative	53380941	C29H30F2N4O5	552.6	CCOC(=O)C(=O)N(CC1=CC(=CC(=C1)F)F)C2=CC3=C(C=C2)OC(CN3C)(C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B1L0JW	2-(Benzyl{2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl}amino)-2-oxoacetic acid	Investigative	25107773	C27H28N4O5	488.5	CC1(CN(C2=C(O1)C=CC(=C2)N(CC3=CC=CC=C3)C(=O)C(=O)O)C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B1PLK3	(2S)-2-[[(2R)-2-[(3S)-3-[[2-(4-Carbamimidoylphenyl)acetyl]amino]-2-oxopyrrolidin-1-yl]-3-carboxypropanoyl]amino]-3-methylbutanoic acid;2,2,2-trifluoroacetic acid	Investigative	44290955	C24H30F3N5O9	589.5	CC(C)[C@@H](C(=O)O)NC(=O)[C@@H](CC(=O)O)N1CC[C@@H](C1=O)NC(=O)CC2=CC=C(C=C2)C(=N)N.C(=O)(C(F)(F)F)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B1TKJ4	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]-[(3,4-difluorophenyl)methyl]amino]acetate	Investigative	53380822	C29H32F2N4O4	538.6	CCOC(=O)CN(CC1=CC(=C(C=C1)F)F)C2=CC3=C(C=C2)N(CC(O3)(C)COC4=CC=C(C=C4)C(=N)N)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B1U7EK	[16-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-3,3,10-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid	Investigative	73350083	C23H39N9O8S2	633.7	C[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(SSC[C@H](C(=O)N[C@@H](C(=O)N1)CCCN=C(N)N)NC(=O)C)(C)C)C(=O)N)CC(=O)O	IC50 = 200000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B1WGI8	2-(2-{2-[2-(2-Acetylamino-acetylamino)-5-guanidino-pentanoylamino]-acetylamino}-3-carboxy-propionylamino)-3-methyl-butyric acid	Investigative	44304496	C21H36N8O9	544.6	CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)C	IC50 = 77000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B2E0QG	(3S)-3-[[2-[[(2R)-2-Acetamido-6-(diaminomethylideneamino)hexanoyl]amino]acetyl]amino]-4-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	44336187	C18H32N8O8	488.5	CC(=O)N[C@H](CCCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 = 68200 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B2U9AP	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-6-yl]-[(4-fluorophenyl)methyl]amino]acetate	Investigative	53380936	C29H33FN4O4	520.6	CCOC(=O)CN(CC1=CC=C(C=C1)F)C2=CC3=C(C=C2)OC(CN3C)(C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B2VE5T	{(R)-7-[(1H-Benzoimidazol-2-ylmethyl)-methyl-carbamoyl]-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-2-yl}-acetic acid	Investigative	10645847	C22H23N5O4	421.4	CN1CC2=C(C=CC(=C2)C(=O)N(C)CC3=NC4=CC=CC=C4N3)N[C@@H](C1=O)CC(=O)O	Ki ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B31WPQ	(2S)-3-Oxo-4-methyl-7-(6-amino-2-pyridinylcarbamoyl)-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2-acetic acid	Investigative	44296106	C18H19N5O4	369.4	CN1CC2=C(C=CC(=C2)C(=O)NC3=CC=CC(=N3)N)N[C@H](C1=O)CC(=O)O	Ki = 160000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B32BSD	(S)-2-Benzyloxycarbonylamino-3-{[3-(4-guanidino-butyl)-4,5-dihydro-isoxazole-5-carbonyl]-amino}-propionic acid	Investigative	44384400	C20H28N6O6	448.5	C1C(ON=C1CCCCN=C(N)N)C(=O)NC[C@@H](C(=O)O)NC(=O)OCC2=CC=CC=C2	IC50 = 55000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B34JFI	6-Oxo-6-[9-(4-amidinobenzoyl)-3,9-diazaspiro[5.5]undecane-3-yl]hexanoic acid	Investigative	44459345	C23H32N4O4	428.5	C1CN(CCC12CCN(CC2)C(=O)C3=CC=C(C=C3)C(=N)N)C(=O)CCCCC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B37RKA	N-[3-(Diethylamino)propyl]-1-[4-(3-methylphenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)pyrazole-4-carboxamide	Investigative	10434644	C22H26F3N5OS	465.5	CCN(CC)CCCNC(=O)C1=C(N(N=C1)C2=NC(=CS2)C3=CC=CC(=C3)C)C(F)(F)F	IC50 = 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B38ZAL	{(S)-7-[(1H-Indol-2-ylmethyl)-carbamoyl]-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-2-yl}-acetic acid	Investigative	18394355	C22H22N4O4	406.4	CN1CC2=C(C=CC(=C2)C(=O)NCC3=CC4=CC=CC=C4N3)N[C@H](C1=O)CC(=O)O	Ki ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B3A7YI	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]-[(3-fluorophenyl)methyl]amino]-2-oxoacetate	Investigative	57398234	C29H31FN4O5	534.6	CCOC(=O)C(=O)N(CC1=CC(=CC=C1)F)C2=CC3=C(C=C2)N(CC(O3)(C)COC4=CC=C(C=C4)C(=N)N)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B3FN9S	(2S)-3-[[2-[(3R,5S)-5-[[(4-Methoxypyridin-2-yl)amino]methyl]-1-phenylmethoxycarbonylpyrrolidin-3-yl]oxyacetyl]amino]-2-[(1-methylcyclohexanecarbonyl)amino]propanoic acid	Investigative	16756623	C32H43N5O8	625.7	CC1(CCCCC1)C(=O)N[C@@H](CNC(=O)CO[C@@H]2C[C@H](N(C2)C(=O)OCC3=CC=CC=C3)CNC4=NC=CC(=C4)OC)C(=O)O	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B3J4BA	3-[2-(3-Guanidino-propionylamino)-phenylsulfanyl]-3-pyridin-3-yl-propionic acid	Investigative	44372962	C18H21N5O3S	387.5	C1=CC=C(C(=C1)NC(=O)CCN=C(N)N)SC(CC(=O)O)C2=CN=CC=C2	IC50 = 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B3VND1	2-(Biphenyl-4-sulfonylamino)-3-({5-[4-(pyridin-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid	Investigative	44352004	C29H33N5O6S	579.7	CN([C@@H](CNC(=O)C1=NOC(C1)CCCCNC2=CC=CC=N2)C(=O)O)S(=O)(=O)C3=CC=C(C=C3)C4=CC=CC=C4	IC50 = 70000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B49DXI	{(S)-4-Methyl-3-oxo-7-[2-(pyrimidin-2-ylamino)-ethylcarbamoyl]-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-2-yl}-acetic acid	Investigative	44296450	C19H22N6O4	398.4	CN1CC2=C(C=CC(=C2)C(=O)NCCNC3=NC=CC=N3)N[C@H](C1=O)CC(=O)O	Ki ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B4AM9K	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-6-yl]-[(3,5-difluorophenyl)methyl]amino]acetate	Investigative	53380823	C29H32F2N4O4	538.6	CCOC(=O)CN(CC1=CC(=CC(=C1)F)F)C2=CC3=C(C=C2)OC(CN3C)(C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B4B3OL	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]-[(4-fluorophenyl)methyl]amino]-2-oxoacetate	Investigative	57398233	C29H31FN4O5	534.6	CCOC(=O)C(=O)N(CC1=CC=C(C=C1)F)C2=CC3=C(C=C2)N(CC(O3)(C)COC4=CC=C(C=C4)C(=N)N)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B4T9AJ	4-Oxo-4-[9-[4-(4-piperidinyl)piperidinocarbonyl]-3-azaspiro[5.5]undecane-3-yl]butyric acid	Investigative	44459645	C25H41N3O4	447.6	C1CC2(CCC1C(=O)N3CCC(CC3)C4CCNCC4)CCN(CC2)C(=O)CCC(=O)O	IC50 = 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B4Y2LX	7-[[(5-Amidino-1H-indol-3-yl)carbonyl]amino]heptanoic acid	Investigative	10853893	C17H22N4O3	330.4	C1=CC2=C(C=C1C(=N)N)C(=CN2)C(=O)NCCCCCCC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B51MVY	6-[2-(4-Pyridinyl)-2,8-diazaspiro[4.5]decane-8-ylcarbonylamino]hexanoic acid	Investigative	44268288	C20H30N4O3	374.5	C1CN(CCC12CCN(C2)C3=CC=NC=C3)C(=O)NCCCCCC(=O)O	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B53NMA	3-[4-Amino(imino)methylamino-1-methylcarboxamido-(1S)-butylcarboxamidomethylcarboxamido]-3-phenethylcarbamoylpropanoic acid	Investigative	10480781	C22H33N7O6	491.5	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NCCC1=CC=CC=C1	IC50 = 75900 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B5B7UV	(2S)-3-[[2-[(3R,5S)-1-(3,3-Dimethylbutanoyl)-5-[[(4-methoxypyridin-2-yl)amino]methyl]pyrrolidin-3-yl]oxyacetyl]amino]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid	Investigative	16756622	C32H45N5O7	611.7	CC1=CC(=C(C(=C1)C)C(=O)N[C@@H](CNC(=O)CO[C@@H]2C[C@H](N(C2)C(=O)CC(C)(C)C)CNC3=NC=CC(=C3)OC)C(=O)O)C	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B5W8HO	(S)-2-Amino-3-[[5-[4-(1H-imidazole-2-ylamino)butyl]-2-isoxazoline-3-yl]carbonylamino]propionic acid	Investigative	10830837	C14H22N6O4	338.36	C1C(ON=C1C(=O)NC[C@@H](C(=O)O)N)CCCCNC2=NC=CN2	IC50 = 84000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B5XIB7	3-Oxo-8-[methyl(4-amidinophenyl)carbamoyl]-2,3,4,5-tetrahydro-1H-2-benzazepine-2-acetic acid	Investigative	44368152	C21H22N4O4	394.4	CN(C1=CC=C(C=C1)C(=N)N)C(=O)C2=CC3=C(CCC(=O)N(C3)CC(=O)O)C=C2	Ki ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B5Z6FV	Arginyl-glycyl-aspartic acid	Investigative	104802	C12H22N6O6	346.34	C(C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N)CN=C(N)N	IC50 = 130000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B60LXF	4-{[1-((R)-6-Amino-2-tert-butoxycarbonylamino-hexanoyl)-piperidine-3-carbonyl]-amino}-butyric acid	Investigative	9980810	C21H38N4O6	442.5	CC(C)(C)OC(=O)N[C@H](CCCCN)C(=O)N1CCCC(C1)C(=O)NCCCC(=O)O	IC50 = 59000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B60UQT	(2S)-2-[(1-Methylcyclohexanecarbonyl)amino]-3-[[2-[(3R,5S)-1-phenylmethoxycarbonyl-5-[(pyridin-2-ylamino)methyl]pyrrolidin-3-yl]oxyacetyl]amino]propanoic acid	Investigative	11721315	C31H41N5O7	595.7	CC1(CCCCC1)C(=O)N[C@@H](CNC(=O)CO[C@@H]2C[C@H](N(C2)C(=O)OCC3=CC=CC=C3)CNC4=CC=CC=N4)C(=O)O	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B63VBZ	2-[(4-Bromophenyl)sulfonylamino]-3-[6-(3-piperidin-4-ylpropoxy)naphthalen-2-yl]propanoic acid;hydrochloride	Investigative	134140093	C27H32BrClN2O5S	612	C1CNCCC1CCCOC2=CC3=C(C=C2)C=C(C=C3)CC(C(=O)O)NS(=O)(=O)C4=CC=C(C=C4)Br.Cl	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B6E9JY	(S)-2-(2,4,6-Trimethylphenylsulfonylamino)-3-[[5-[4-(isoquinolin-1-ylamino)butyl]-2-isoxazolin-3-yl]carbonylamino]propionic acid	Investigative	10507483	C29H35N5O6S	581.7	CC1=CC(=C(C(=C1)C)S(=O)(=O)N[C@@H](CNC(=O)C2=NOC(C2)CCCCNC3=NC=CC4=CC=CC=C43)C(=O)O)C	IC50 = 78000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B6Q3LX	3-[4-Amino(imino)methylamino-1-methylcarboxamido-(1S)-butylcarboxamidomethylcarboxamido]-3-[1-carbamoyl-2-(4-hydroxyphenyl)-(1S)-ethylcarbamoyl]propanoic acid	Investigative	15088314	C23H34N8O8	550.6	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N	IC50 = 102000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B6T8YA	(3R)-3-(6-Methoxypyridin-3-yl)-4-[1-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propanoyl]piperidin-4-yl]butanoic acid	Investigative	42607047	C26H34N4O4	466.6	COC1=NC=C(C=C1)[C@H](CC2CCN(CC2)C(=O)CCC3=NC4=C(CCCN4)C=C3)CC(=O)O	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B6WE0S	(3S)-3-[[2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid	Investigative	15088313	C19H34N8O7	486.5	CC(C)[C@@H](C(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)C	IC50 = 55500 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B7GB0X	Acetic acid;ethyl (2S)-2-[[(2S)-2-benzyl-3-[[4-[(4-carbamimidoylphenyl)methyl]-3-oxo-1,4-benzoxazin-7-yl]amino]-3-oxopropanoyl]amino]propanoate	Investigative	44400344	C33H37N5O8	631.7	CCOC(=O)[C@H](C)NC(=O)[C@H](CC1=CC=CC=C1)C(=O)NC2=CC3=C(C=C2)N(C(=O)CO3)CC4=CC=C(C=C4)C(=N)N.CC(=O)O	Ki = 59050 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B7GZE1	{(S)-7-[(1H-Benzoimidazol-2-ylmethyl)-carbamoyl]-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-2-yl}-acetic acid	Investigative	10692763	C21H21N5O4	407.4	CN1CC2=C(C=CC(=C2)C(=O)NCC3=NC4=CC=CC=C4N3)N[C@H](C1=O)CC(=O)O	Ki = 52000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B7T9PX	Ethyl 2-(benzyl{2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl}amino)-2-oxoacetate	Investigative	25107571	C29H32N4O5	516.6	CCOC(=O)C(=O)N(CC1=CC=CC=C1)C2=CC3=C(C=C2)N(CC(O3)(C)COC4=CC=C(C=C4)C(=N)N)C	IC50 = 52000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B7U2HP	(3S)-3-[[2-[[(2S)-2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid	Investigative	15088301	C29H46N12O8	690.8	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N	IC50 = 113000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B7XWN8	{7-[2-(1H-Benzoimidazol-2-yl)-ethylcarbamoyl]-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-2-yl}-acetic acid	Investigative	10526203	C22H23N5O4	421.4	CN1CC2=C(C=CC(=C2)C(=O)NCCC3=NC4=CC=CC=C4N3)NC(C1=O)CC(=O)O	Ki ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B7ZTN0	(S)-2-(2,4,6-Trimethylphenylsulfonylamino)-3-[[5-[3-(1H-imidazol-2-ylcarbamoyl)propyl]-2-isoxazolin-3-yl]carbonylamino]propionic acid	Investigative	10369856	C23H30N6O7S	534.6	CC1=CC(=C(C(=C1)C)S(=O)(=O)N[C@@H](CNC(=O)C2=NOC(C2)CCCC(=O)NC3=NC=CN3)C(=O)O)C	IC50 = 61000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B86JDA	1-[(S)-2-(4-Amidinobenzoylamino)propionyl]piperidine-4-carboxylic acid	Investigative	44307259	C17H22N4O4	346.4	C[C@@H](C(=O)N1CCC(CC1)C(=O)O)NC(=O)C2=CC=C(C=C2)C(=N)N	IC50 = 109647.82 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B87IWS	N-[3-(Diethylamino)propyl]-1-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)pyrazole-4-carboxamide	Investigative	10050154	C22H26F3N5OS	465.5	CCN(CC)CCCNC(=O)C1=C(N(N=C1)C2=NC(=CS2)C3=CC=C(C=C3)C)C(F)(F)F	IC50 = 70000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B8AE3C	3-[Methyl(1H-benzimidazole-2-ylmethyl)carbamoyl]-10,11-dihydro-5H-dibenzo[a,d]cycloheptene-10-acetic acid	Investigative	9911060	C27H25N3O3	439.5	CN(CC1=NC2=CC=CC=C2N1)C(=O)C3=CC4=C(CC(C5=CC=CC=C5C4)CC(=O)O)C=C3	Ki ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B8J0YW	3-[4-(3-Guanidino-benzoylamino)-phenylsulfanyl]-3-pyridin-3-yl-propionic acid	Investigative	9828979	C22H21N5O3S	435.5	C1=CC(=CC(=C1)N=C(N)N)C(=O)NC2=CC=C(C=C2)SC(CC(=O)O)C3=CN=CC=C3	EC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B8U2SJ	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-6-yl]-[(3-fluorophenyl)methyl]amino]acetate	Investigative	53380937	C29H33FN4O4	520.6	CCOC(=O)CN(CC1=CC(=CC=C1)F)C2=CC3=C(C=C2)OC(CN3C)(C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B8U7DQ	(S)-2-Benzyloxycarbonylamino-3-{[5-(3-guanidino-propyl)-4,5-dihydro-isoxazole-3-carbonyl]-amino}-propionic acid	Investigative	44383755	C19H26N6O6	434.4	C1C(ON=C1C(=O)NC[C@@H](C(=O)O)NC(=O)OCC2=CC=CC=C2)CCCN=C(N)N	IC50 = 53000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B8ZTO1	6-[3-(Aminomethyl)benzyloxy]-1,2,3,4-tetrahydro-1-oxoisoquinoline-2-acetic acid	Investigative	10593246	C19H20N2O4	340.4	C1CN(C(=O)C2=C1C=C(C=C2)OCC3=CC=CC(=C3)CN)CC(=O)O	IC50 = 77000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B94PID	2-[(2-Ethyl-6-methylbenzoyl)amino]-3-[4-[4-[(pyridin-2-ylamino)methyl]piperidin-1-yl]phenyl]propanoic acid	Investigative	24873110	C30H36N4O3	500.6	CCC1=CC=CC(=C1C(=O)NC(CC2=CC=C(C=C2)N3CCC(CC3)CNC4=CC=CC=N4)C(=O)O)C	IC50 = 87200 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B9FBI5	7-[[4-(2-Thiazolylamino)butyrylamino]methyl]-6,9-dihydro-5H-benzocycloheptene-5-acetic acid	Investigative	22594331	C21H25N3O3S	399.5	C1C=C(CC(C2=CC=CC=C21)CC(=O)O)CNC(=O)CCCNC3=NC=CS3	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B9FZ2I	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]-[(3,5-difluorophenyl)methyl]amino]-2-oxoacetate	Investigative	57395044	C29H30F2N4O5	552.6	CCOC(=O)C(=O)N(CC1=CC(=CC(=C1)F)F)C2=CC3=C(C=C2)N(CC(O3)(C)COC4=CC=C(C=C4)C(=N)N)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B9GF1P	2-(Benzyl{2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl}amino)-2-oxoacetic Acid	Investigative	25107635	C27H28N4O5	488.5	CC1(CN(C2=C(O1)C=C(C=C2)N(CC3=CC=CC=C3)C(=O)C(=O)O)C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	B9T3DL	(S)-2-(2,4,6-Trimethylphenylsulfonylamino)-3-[[5-[2-[3-(1H-imidazol-2-yl)ureido]ethyl]-2-isoxazolin-3-yl]carbonylamino]propionic acid	Investigative	10697605	C22H29N7O7S	535.6	CC1=CC(=C(C(=C1)C)S(=O)(=O)N[C@@H](CNC(=O)C2=NOC(C2)CCNC(=O)NC3=NC=CN3)C(=O)O)C	IC50 = 120000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BA3BV6	(3S)-4-[[(1S)-1-Carboxy-2-phenylethyl]amino]-3-[(3R)-3-[[(2S)-5-(diaminomethylideneamino)-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid;2,2,2-trifluoroacetic acid	Investigative	44291463	C33H40F3N7O11	767.7	C1CN(C(=O)[C@@H]1NC(=O)[C@H](CCCN=C(N)N)NC(=O)OCC2=CC=CC=C2)[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O.C(=O)(C(F)(F)F)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BA7KJ8	1-[3-(4-Guanidinobenzoylamino)propionyl]piperidine-4-acetic acid	Investigative	44306947	C18H25N5O4	375.4	C1CN(CCC1CC(=O)O)C(=O)CCNC(=O)C2=CC=C(C=C2)N=C(N)N	IC50 = 199526.23 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BACQ24	3-{[5-(3-Guanidino-3-oxo-propyl)-thiophene-2-carbonyl]-amino}-3-naphthalen-1-yl-propionic acid	Investigative	9869692	C25H26N4O4S	478.6	C1CNC(=NC1)NC(=O)CCC2=CC=C(S2)C(=O)NC(CC(=O)O)C3=CC=CC4=CC=CC=C43	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BAJ5B9	6-[(4-Piperidinyl)methoxy]-1,2,3,4-tetrahydro-1-oxoisoquinoline-2-acetic acid	Investigative	10639257	C17H22N2O4	318.4	C1CNCCC1COC2=CC3=C(C=C2)C(=O)N(CC3)CC(=O)O	IC50 = 55000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BAL57Y	6-Oxo-6-[8-(4-pyridinyl)-2,8-diazaspiro[4.5]decane-2-yl]hexanoic acid	Investigative	9950075	C19H27N3O3	345.4	C1CN(CCC12CCN(C2)C(=O)CCCCC(=O)O)C3=CC=NC=C3	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BB9IS4	2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({5-[4-(pyridin-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid	Investigative	10483616	C30H35N5O6S	593.7	CC1=CC(=CC(=C1S(=O)(=O)N[C@@H](CNC(=O)C2=NOC(C2)CCCCNC3=CC=CC=N3)C(=O)O)C)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BBI3O0	2-[1-[2-[3-(4-Carbamimidoylphenyl)-4,5-dihydro-1,2-oxazol-5-yl]acetyl]piperidin-2-yl]acetic acid;2,2,2-trifluoroacetic acid	Investigative	44359533	C21H25F3N4O6	486.4	C1CCN(C(C1)CC(=O)O)C(=O)CC2CC(=NO2)C3=CC=C(C=C3)C(=N)N.C(=O)(C(F)(F)F)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BC1V0U	5-Oxo-5-[9-[4-(4-piperidinyl)piperidinocarbonyl]-3-azaspiro[5.5]undecane-3-yl]valeric acid	Investigative	44459643	C26H43N3O4	461.6	C1CC2(CCC1C(=O)N3CCC(CC3)C4CCNCC4)CCN(CC2)C(=O)CCCC(=O)O	IC50 = 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BC20US	Ethyl 2-(benzyl{2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl}amino)acetate	Investigative	25107708	C29H34N4O4	502.6	CCOC(=O)CN(CC1=CC=CC=C1)C2=CC3=C(C=C2)OC(CN3C)(C)COC4=CC=C(C=C4)C(=N)N	IC50 = 54000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BCGL91	2-[2-(4-Carbamimidoylbenzyloxy)-4-methyl-3-oxo-N-phenyl-3,4-dihydro-2H-1,4-benzoxazine-7-carbonylamino]acetic acid	Investigative	25107707	C26H24N4O6	488.5	CN1C2=C(C=C(C=C2)C(=O)N(CC(=O)O)C3=CC=CC=C3)OC(C1=O)OCC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BD2BT4	2-(2-{2-[2-(2-Amino-acetylamino)-5-guanidino-pentanoylamino]-acetylamino}-3-carboxy-propionylamino)-3-methyl-butyric acid	Investigative	44304547	C19H34N8O8	502.5	CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CN	IC50 = 75000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BD4P1Q	(S)-2-(1-Naphthylsulfonylamino)-3-[[5-[4-(2-pyridylamino)butyl]-2-isoxazolin-3-yl]carbonylamino]propionic acid	Investigative	11800573	C26H29N5O6S	539.6	C1C(ON=C1C(=O)NC[C@@H](C(=O)O)NS(=O)(=O)C2=CC=CC3=CC=CC=C32)CCCCNC4=CC=CC=N4	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BD76CY	6-Carboxymethyl-12-(3-guanidino-propyl)-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaaza-cyclononadecane-3-carboxylic acid	Investigative	44304576	C20H32N8O9S	560.6	C1CSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC1=O)CCCN=C(N)N)CC(=O)O)C(=O)O	IC50 = 64300 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BD92KL	(S)-2-(4-Isopropylphenylsulfonylamino)-3-[[5-[4-(2-pyridylamino)butyl]-2-isoxazolin-3-yl]carbonylamino]propionic acid	Investigative	10839976	C25H33N5O6S	531.6	CC(C)C1=CC=C(C=C1)S(=O)(=O)N[C@@H](CNC(=O)C2=NOC(C2)CCCCNC3=CC=CC=N3)C(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BDOE57	[(4S,7R,13R,16S)-16-Acetylamino-14-benzyl-4-carbamoyl-13-(3-guanidino-propyl)-3,3-dimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid	Investigative	44378360	C29H43N9O8S2	709.8	CC(=O)N[C@@H]1CSSC([C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@H](N(C1=O)CC2=CC=CC=C2)CCCN=C(N)N)CC(=O)O)C(=O)N)(C)C	Ki ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BE07DG	2-[(6S,12R,18R,21S)-18-[3-(Diaminomethylideneamino)propyl]-2,5,11,14,17,20-hexaoxo-1,4,10,13,16,19-hexazatricyclo[19.3.0.06,10]tetracosan-12-yl]acetic acid	Investigative	44351788	C24H37N9O8	579.6	C1C[C@H]2C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N3CCC[C@H]3C(=O)NCC(=O)N2C1)CC(=O)O)CCCN=C(N)N	IC50 = 76600 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BE83UX	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-6-yl]-[(3-fluorophenyl)methyl]amino]-2-oxoacetate	Investigative	56683905	C29H31FN4O5	534.6	CCOC(=O)C(=O)N(CC1=CC(=CC=C1)F)C2=CC3=C(C=C2)OC(CN3C)(C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BE9Q7D	(4R)-4-[[2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-5-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid	Investigative	15088310	C18H32N8O8	488.5	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 = 97000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BF1PH7	4-[Benzyl-[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]amino]-4-oxobutanoic acid	Investigative	25107636	C29H32N4O5	516.6	CC1(CN(C2=C(O1)C=C(C=C2)N(CC3=CC=CC=C3)C(=O)CCC(=O)O)C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BFA69K	2-[(8S,11S,14S,20S)-2,20-Diamino-8-benzyl-11-(hydroxymethyl)-4,7,10,13,16,19-hexaoxo-1,3,6,9,12,15,18-heptazacyclotricosen-14-yl]acetic acid	Investigative	73356070	C26H37N9O9	619.6	C1C[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NC(=NC1)N)CC2=CC=CC=C2)CO)CC(=O)O)N	Ki = 75000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BFR7Y6	(2S)-3-[[2-[(3R,5S)-1-(3,3-Dimethylbutanoyl)-5-[[(4-methoxypyridin-2-yl)amino]methyl]pyrrolidin-3-yl]oxyacetyl]amino]-2-[(1-methylcyclohexanecarbonyl)amino]propanoic acid	Investigative	16756957	C30H47N5O7	589.7	CC1(CCCCC1)C(=O)N[C@@H](CNC(=O)CO[C@@H]2C[C@H](N(C2)C(=O)CC(C)(C)C)CNC3=NC=CC(=C3)OC)C(=O)O	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BGC63Z	(S)-2-((S)-3-Carboxy-2-{4-[(E)-3-(4-guanidino-phenyl)-acryloylamino]-butyrylamino}-propionylamino)-3-methyl-butyric acid	Investigative	44295211	C23H32N6O7	504.5	CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCNC(=O)/C=C/C1=CC=C(C=C1)N=C(N)N	IC50 = 70000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BGNI46	Acetyl-arginyl-glycyl-aspartyl-serinamide	Investigative	3081210	C17H30N8O8	474.5	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N	Ki = 62000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BH6IN5	3-Hexyl-7-[[(5-amidino-1H-indol-2-yl)carbonyl]amino]heptanoic acid	Investigative	10811745	C23H34N4O3	414.5	CCCCCCC(CCCCNC(=O)C1=CC2=C(N1)C=CC(=C2)C(=N)N)CC(=O)O	IC50 = 59000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BHI0P8	Ac-RGD-NH2	Investigative	15088315	C14H25N7O6	387.39	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N	IC50 = 138000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BHST74	beta-[[[(5-Amidino-1H-indol-2-yl)carbonylamino]acetyl]amino]benzenepropanoic acid	Investigative	10740150	C21H21N5O4	407.4	C1=CC=C(C=C1)C(CC(=O)O)NC(=O)CNC(=O)C2=CC3=C(N2)C=CC(=C3)C(=N)N	IC50 = 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BI2C5B	2-Butyl-7-[[(5-amidino-1H-indol-2-yl)carbonyl]amino]heptanoic acid	Investigative	10596310	C21H30N4O3	386.5	CCCCC(CCCCCNC(=O)C1=CC2=C(N1)C=CC(=C2)C(=N)N)C(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BI2LO9	(2S)-2-[(2-Ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[(pyridin-2-ylamino)methyl]piperidin-1-yl]phenyl]propanoic acid	Investigative	46224858	C30H35FN4O3	518.6	CCC1=C(C(=CC(=C1)F)C)C(=O)N[C@@H](CC2=CC=C(C=C2)N3CCC(CC3)CNC4=CC=CC=N4)C(=O)O	IC50 = 121000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BI3BK6	2-[2-(Carboxymethoxy)-4-[2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carbonylamino)acetyl]phenoxy]acetic acid	Investigative	9955286	C20H20N2O8S	448.4	C1CNCC2=C1SC(=C2)C(=O)NCC(=O)C3=CC(=C(C=C3)OCC(=O)O)OCC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BI49QZ	(2S)-3-[[2-[(3R,5S)-5-[[(4-Methoxypyridin-2-yl)amino]methyl]-1-phenylmethoxycarbonylpyrrolidin-3-yl]oxyacetyl]amino]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid	Investigative	16756621	C34H41N5O8	647.7	CC1=CC(=C(C(=C1)C)C(=O)N[C@@H](CNC(=O)CO[C@@H]2C[C@H](N(C2)C(=O)OCC3=CC=CC=C3)CNC4=NC=CC(=C4)OC)C(=O)O)C	IC50 = 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BIC38R	8-[[(5-Amidino-1H-indol-3-yl)carbonyl]amino]octanoic acid	Investigative	10617432	C18H24N4O3	344.4	C1=CC2=C(C=C1C(=N)N)C(=CN2)C(=O)NCCCCCCCC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BID03Y	3-{[1-(3-Piperidin-4-yl-propionyl)-piperidine-3-carbonyl]-amino}-cyclohexanecarboxylic acid	Investigative	44316563	C21H35N3O4	393.5	C1CC(CC(C1)NC(=O)C2CCCN(C2)C(=O)CCC3CCNCC3)C(=O)O	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BIK52B	Gly-Arg-Gly-Asp-Tyr	Investigative	9872696	C23H34N8O9	566.6	C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)O	IC50 = 170000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BILU71	3-[2-(3-Piperidin-4-ylmethyl-4,5-dihydro-isoxazol-5-yl)-acetylamino]-propionic acid	Investigative	10780340	C14H23N3O4	297.35	C1CNCCC1CC2=NOC(C2)CC(=O)NCCC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BJR59A	2-[(2-Ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[(pyridin-2-ylamino)methyl]piperidin-1-yl]phenyl]propanoic acid	Investigative	24872070	C30H35FN4O3	518.6	CCC1=C(C(=CC(=C1)F)C)C(=O)NC(CC2=CC=C(C=C2)N3CCC(CC3)CNC4=CC=CC=N4)C(=O)O	IC50 = 71700 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BJVQ52	2-[(1R,6S,7R,8S,9R,23S,24R,25S)-19-[3-(Diaminomethylideneamino)propyl]-7,8,24,25-tetrahydroxy-4,12,15,18,21-pentaoxo-26,27-dioxa-3,11,14,17,20-pentazatricyclo[21.2.1.16,9]heptacosan-13-yl]acetic acid	Investigative	44341096	C26H42N8O13	674.7	C1[C@H]2[C@@H]([C@@H]([C@H](O2)CNC(=O)C(NC(=O)CNC(=O)C(NC(=O)C[C@H]3[C@@H]([C@@H]([C@H](O3)CNC1=O)O)O)CCCN=C(N)N)CC(=O)O)O)O	IC50 = 198000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BK26LS	beta-[[(2S)-1-[(5-Amidinobenzofuran-2-yl)carbonyl]-2-pyrrolidinyl]carbonylamino]benzenepropanoic acid	Investigative	10765872	C24H24N4O5	448.5	C1C[C@H](N(C1)C(=O)C2=CC3=C(O2)C=CC(=C3)C(=N)N)C(=O)NC(CC(=O)O)C4=CC=CC=C4	IC50 = 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BK4O9M	N-[3-(Diethylamino)propyl]-1-(4-phenyl-1,3-thiazol-2-yl)-5-(trifluoromethyl)pyrazole-4-carboxamide	Investigative	10478966	C21H24F3N5OS	451.5	CCN(CC)CCCNC(=O)C1=C(N(N=C1)C2=NC(=CS2)C3=CC=CC=C3)C(F)(F)F	IC50 = 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BK4PF6	4-[2-(4-Pyridinyl)-2,8-diazaspiro[4.5]decane-8-ylcarbonylamino]butyric acid	Investigative	44268287	C18H26N4O3	346.4	C1CN(CCC12CCN(C2)C3=CC=NC=C3)C(=O)NCCCC(=O)O	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BK50EM	3-{3-[(5-Carbamimidoyl-1H-indole-2-carbonyl)-amino]-4,4,4-trifluoro-butyrylamino}-3-phenyl-propionic acid	Investigative	10743635	C23H22F3N5O4	489.4	C1=CC=C(C=C1)C(CC(=O)O)NC(=O)CC(C(F)(F)F)NC(=O)C2=CC3=C(N2)C=CC(=C3)C(=N)N	IC50 = 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BK72PZ	Ethyl 4-[benzyl-[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-6-yl]amino]-4-oxobutanoate	Investigative	25107573	C31H36N4O5	544.6	CCOC(=O)CCC(=O)N(CC1=CC=CC=C1)C2=CC3=C(C=C2)OC(CN3C)(C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BKI6L4	6,15-Bis-carboxymethyl-12-(3-guanidino-propyl)-1,5,8,11,14,17-hexaoxo-1lambda*4*-thia-4,7,10,13,16-pentaaza-cyclooctadecane-3-carboxylic acid	Investigative	44304469	C21H32N8O12S	620.6	C1[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CS1=O)CC(=O)O)CCCN=C(N)N)CC(=O)O)C(=O)O	IC50 = 66000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BKJM56	2-[(2R,5S,11S,14R)-11-(Carboxymethyl)-5,14-bis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]acetic acid	Investigative	44359766	C24H40N12O10	656.6	C1C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CCCN=C(N)N)CC(=O)O)CCCN=C(N)N)CC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BKT78N	2-Ethyl-7-[[(5-amidino-1H-indol-2-yl)carbonyl]amino]heptanoic acid	Investigative	10666108	C19H26N4O3	358.4	CCC(CCCCCNC(=O)C1=CC2=C(N1)C=CC(=C2)C(=N)N)C(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BL8FM3	[3-Carbamoyl-12-(3-guanidino-propyl)-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaaza-cyclooctadec-6-yl]-acetic acid	Investigative	44305004	C19H31N9O8S	545.6	C1[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)CS1)CCCN=C(N)N)CC(=O)O)C(=O)N	IC50 = 150000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BLD17A	(3S)-3-[1-[4-(5,6,7,8-Tetrahydro-1,8-naphthyridin-2-yl)butanoyl]piperidin-4-yl]-3-(1,2,3,4-tetrahydroquinolin-3-yl)propanoic acid	Investigative	42607050	C29H38N4O3	490.6	C1CC2=C(NC1)N=C(C=C2)CCCC(=O)N3CCC(CC3)[C@H](CC(=O)O)C4CC5=CC=CC=C5NC4	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BLY02F	(S)-2-Tert-Butoxycarbonylamino-3-[4-(3-tert-butylamino-propoxy)-phenyl]-propionic acid	Investigative	10340606	C21H34N2O5	394.5	CC(C)(C)NCCCOC1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)OC(C)(C)C	IC50 = 95000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BLYE20	(S)-3-[(R)-2-((S)-2-Benzyloxycarbonylamino-5-guanidino-pentanoylamino)-propionylamino]-N-((S)-1-methoxycarbonyl-2-phenyl-ethyl)-succinamic acid	Investigative	44291467	C31H41N7O9	655.7	C[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)OC)NC(=O)[C@H](CCCN=C(N)N)NC(=O)OCC2=CC=CC=C2	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BM40CG	(S)-2-[(S)-3-Carboxy-2-((S)-4-methyl-2-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-pentanoylamino)-propionylamino]-3-methyl-butyric acid	Investigative	9851886	C31H41N5O8	611.7	CC1=CC=CC=C1NC(=O)NC2=CC=C(C=C2)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BMD4K2	(3S)-3-[8-(Diaminomethylideneamino)octanoylamino]-4-oxo-4-(2-phenylethylamino)butanoic acid	Investigative	15677293; 44363837	C21H33N5O4	419.5	C1=CC=C(C=C1)CCNC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCN=C(N)N	IC50 = 60000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BMKA61	(S)-3-[(S)-2-((S)-2-Benzyloxycarbonylamino-5-guanidino-pentanoylamino)-propionylamino]-N-((S)-1-methoxycarbonyl-2-phenyl-ethyl)-succinamic acid	Investigative	44291757	C31H41N7O9	655.7	C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)OC)NC(=O)[C@H](CCCN=C(N)N)NC(=O)OCC2=CC=CC=C2	IC50 = 78000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BN83JH	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-6-yl]-[(3,4-difluorophenyl)methyl]amino]acetate	Investigative	56660094	C29H32F2N4O4	538.6	CCOC(=O)CN(CC1=CC(=C(C=C1)F)F)C2=CC3=C(C=C2)OC(CN3C)(C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BNM67P	(2S)-2-(3-Oxo-1H-isoindol-2-yl)-3-[4-[4-[(pyridin-2-ylamino)methyl]piperidin-1-yl]phenyl]propanoic acid	Investigative	46224861	C28H30N4O3	470.6	C1CN(CCC1CNC2=CC=CC=N2)C3=CC=C(C=C3)C[C@@H](C(=O)O)N4CC5=CC=CC=C5C4=O	IC50 = 76700 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BO30XR	(2R)-3-[[5-[4-(1H-Imidazol-2-ylamino)butyl]-4,5-dihydro-1,2-oxazole-3-carbonyl]amino]-2-[(2,4,6-trimethylphenyl)sulfonylamino]propanoic acid	Investigative	71459889	C23H32N6O6S	520.6	CC1=CC(=C(C(=C1)C)S(=O)(=O)N[C@H](CNC(=O)C2=NOC(C2)CCCCNC3=NC=CN3)C(=O)O)C	IC50 = 68000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BO9CY5	5-[[(5-Amidino-1H-indol-2-yl)carbonyl]amino]pentanoic acid	Investigative	10780686	C15H18N4O3	302.33	C1=CC2=C(C=C1C(=N)N)C=C(N2)C(=O)NCCCCC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BOB5R6	[7-(1H-Benzoimidazol-2-ylcarbamoyl)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-2-yl]-acetic acid	Investigative	10715577	C20H19N5O4	393.4	CN1CC2=C(C=CC(=C2)C(=O)NC3=NC4=CC=CC=C4N3)NC(C1=O)CC(=O)O	Ki ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BOG19I	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-6-yl]-[(3,4-difluorophenyl)methyl]amino]-2-oxoacetate	Investigative	56683906	C29H30F2N4O5	552.6	CCOC(=O)C(=O)N(CC1=CC(=C(C=C1)F)F)C2=CC3=C(C=C2)OC(CN3C)(C)COC4=CC=C(C=C4)C(=N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BOJ5C8	2-[(4-Bromophenyl)sulfonylamino]-3-[6-(piperidin-4-ylmethoxy)naphthalen-2-yl]propanoic acid;hydrochloride	Investigative	134137713	C25H28BrClN2O5S	583.9	C1CNCCC1COC2=CC3=C(C=C2)C=C(C=C3)CC(C(=O)O)NS(=O)(=O)C4=CC=C(C=C4)Br.Cl	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BOVH95	Acetic acid;ethyl 1-[4-[(5R)-5-[[(4-carbamimidoylbenzoyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylate	Investigative	73353475	C28H35N5O7	553.6	CCOC(=O)C1CCN(CC1)C2=CC=C(C=C2)N3C[C@H](OC3=O)CNC(=O)C4=CC=C(C=C4)C(=N)N.CC(=O)O	IC50 = 96000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BPEW05	(2S)-3-[[2-[(3S,5R)-1-(3,3-Dimethylbutanoyl)-5-[(pyridin-2-ylamino)methyl]pyrrolidin-3-yl]oxyacetyl]amino]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid	Investigative	46226894	C31H43N5O6	581.7	CC1=CC(=C(C(=C1)C)C(=O)N[C@@H](CNC(=O)CO[C@H]2C[C@@H](N(C2)C(=O)CC(C)(C)C)CNC3=CC=CC=N3)C(=O)O)C	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BPH4J3	(2S)-3-[[2-[(3R,5S)-1-Phenylmethoxycarbonyl-5-[(pyridin-2-ylamino)methyl]pyrrolidin-3-yl]oxyacetyl]amino]-2-[(2,4,6-trimethylbenzoyl)amino]propanoic acid	Investigative	16756505	C33H39N5O7	617.7	CC1=CC(=C(C(=C1)C)C(=O)N[C@@H](CNC(=O)CO[C@@H]2C[C@H](N(C2)C(=O)OCC3=CC=CC=C3)CNC4=CC=CC=N4)C(=O)O)C	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BPUN61	2-[(2S,5R,11S,14S)-11-(Carboxymethyl)-5,14-bis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,18-hexaoxo-1,4,7,10,13,16-hexazacyclooctadec-2-yl]acetic acid	Investigative	44359767	C24H40N12O10	656.6	C1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CCCN=C(N)N)CC(=O)O)CCCN=C(N)N)CC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BQ2MZ8	Arg-gly-asp-ser	Investigative	107775	C15H27N7O8	433.42	C(C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N	IC50 = 55000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BQ6Y5Z	{[1-((S)-6-Amino-2-tert-butoxycarbonylamino-hexanoyl)-piperidine-3-carbonyl]-amino}-acetic acid	Investigative	44287428	C19H34N4O6	414.5	CC(C)(C)OC(=O)N[C@@H](CCCCN)C(=O)N1CCCC(C1)C(=O)NCC(=O)O	IC50 = 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BR5OE6	(S)-2-Benzyloxycarbonylamino-3-[3-(5-guanidinomethyl-4,5-dihydro-isoxazol-3-yl)-propionylamino]-propionic acid	Investigative	44384519	C19H26N6O6	434.4	C1C(ON=C1CCC(=O)NC[C@@H](C(=O)O)NC(=O)OCC2=CC=CC=C2)CN=C(N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BR6E7F	1-[Methyl(4-guanidinobenzoyl)aminoacetyl]piperidine-4-carboxylic acid	Investigative	44306747	C17H23N5O4	361.4	CN(CC(=O)N1CCC(CC1)C(=O)O)C(=O)C2=CC=C(C=C2)N=C(N)N	IC50 = 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BRB8H9	[19-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicos-7-yl]-acetic acid	Investigative	44336279	C22H36N10O9S2	648.7	CC(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC1=O)CCCN=C(N)N)CC(=O)O)C(=O)N	IC50 = 52000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BRPI60	(2R)-2-[(2-Ethyl-4-fluoro-6-methylbenzoyl)amino]-3-[4-[4-[(pyridin-2-ylamino)methyl]piperidin-1-yl]phenyl]propanoic acid	Investigative	46224859	C30H35FN4O3	518.6	CCC1=C(C(=CC(=C1)F)C)C(=O)N[C@H](CC2=CC=C(C=C2)N3CCC(CC3)CNC4=CC=CC=N4)C(=O)O	IC50 = 159000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BS09QN	3-(3-Pyridin-4-yl-3-aza-spiro[5.5]undec-9-ylamino)-propionic acid	Investigative	44459648	C18H27N3O2	317.4	C1CC2(CCC1NCCC(=O)O)CCN(CC2)C3=CC=NC=C3	IC50 = 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BS2IR5	1-[4-[(5S)-5-[[(2-Amino-1,3-thiazole-5-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylic acid;2,2,2-trifluoroacetic acid	Investigative	73356533	C22H24F3N5O7S	559.5	C1CN(CCC1C(=O)O)C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CN=C(S4)N.C(=O)(C(F)(F)F)O	IC50 = 78400 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BS6BQ9	[4-Methyl-3-oxo-7-(4-phenyl-piperazine-1-carbonyl)-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-2-yl]-acetic acid	Investigative	10574237	C23H26N4O4	422.5	CN1CC2=C(C=CC(=C2)C(=O)N3CCN(CC3)C4=CC=CC=C4)NC(C1=O)CC(=O)O	Ki ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BS7N4X	[16-Acetylamino-13-(4-amino-butyl)-4-carbamoyl-3,3-dimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid	Investigative	73353037	C22H37N7O8S2	591.7	CC(=O)N[C@@H]1CSSC([C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@H](NC1=O)CCCCN)CC(=O)O)C(=O)N)(C)C	IC50 = 55300 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BS85RX	3-[4-(6-Aminohexyloxy)phenyl]propanoic acid	Investigative	10422987	C15H23NO3	265.35	C1=CC(=CC=C1CCC(=O)O)OCCCCCCN	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BSDQ17	4-[[(5-Amidino-1H-indol-2-yl)carbonylaminoacetyl]amino]butanoic acid	Investigative	10545460	C16H19N5O4	345.35	C1=CC2=C(C=C1C(=N)N)C=C(N2)C(=O)NCC(=O)NCCCC(=O)O	IC50 = 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BTC71E	[16-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-3,3,11-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid	Investigative	44378378	C23H39N9O8S2	633.7	CC(=O)N[C@@H]1CSSC([C@@H](NC(=O)[C@H](NC(=O)CN(C(=O)[C@H](NC1=O)CCCN=C(N)N)C)CC(=O)O)C(=O)N)(C)C	IC50 = 73400 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BU7O8G	Acetic acid;ethyl 1-[4-[(5S)-5-[[(4-carbamimidoylphenyl)methylamino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylate	Investigative	73350497	C28H37N5O6	539.6	CCOC(=O)C1CCN(CC1)C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNCC4=CC=C(C=C4)C(=N)N.CC(=O)O	IC50 = 55000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BU9D3W	2-(2-{2-[2-(2-Amino-acetylamino)-5-guanidino-pentanoylamino]-acetylamino}-3-carboxy-propionylamino)-4-methyl-pentanoic acid	Investigative	44304953	C20H36N8O8	516.5	CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CN	IC50 = 170000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BUD86G	1-[(S)-2-[4-(Guanidinomethyl)benzoylamino]propionyl]piperidine-4-acetic acid	Investigative	44307099	C19H27N5O4	389.4	C[C@@H](C(=O)N1CCC(CC1)CC(=O)O)NC(=O)C2=CC=C(C=C2)CN=C(N)N	IC50 = 91201.08 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BV35KH	3-{2-[(Z)-4-Carbamimidoyl-benzoylimino]-3,4-dimethyl-2,3-dihydro-thiazol-5-yl}-propionic acid	Investigative	9863046	C16H18N4O3S	346.4	CC1=C(SC(=NC(=O)C2=CC=C(C=C2)C(=N)N)N1C)CCC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BV3Z5S	(S)-2-((S)-4-Methyl-2-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-pentanoylamino)-succinic acid	Investigative	11799915	C26H32N4O7	512.6	CC1=CC=CC=C1NC(=O)NC2=CC=C(C=C2)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BV47TI	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]-[(4-fluorophenyl)methyl]amino]acetate	Investigative	53380938	C29H33FN4O4	520.6	CCOC(=O)CN(CC1=CC=C(C=C1)F)C2=CC3=C(C=C2)N(CC(O3)(C)COC4=CC=C(C=C4)C(=N)N)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BV4K5A	(S)-2-Benzyloxycarbonylamino-3-{4-[3-(1,1,3,3-tetramethyl-butylamino)-propoxy]-phenyl}-propionic acid	Investigative	10254771	C28H40N2O5	484.6	CC(C)(C)CC(C)(C)NCCCOC1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)OCC2=CC=CC=C2	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BV8YT4	3-[4-(3-Guanidino-propionylamino)-phenylsulfanyl]-3-pyridin-3-yl-propionic acid	Investigative	44373170	C18H21N5O3S	387.5	C1=CC(=CN=C1)C(CC(=O)O)SC2=CC=C(C=C2)NC(=O)CCN=C(N)N	IC50 = 87000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BVB60S	2-[[2-[(4-Carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]-[(3-fluorophenyl)methyl]amino]acetic acid	Investigative	57400272	C27H29FN4O4	492.5	CC1(CN(C2=C(O1)C=C(C=C2)N(CC3=CC(=CC=C3)F)CC(=O)O)C)COC4=CC=C(C=C4)C(=N)N	IC50 = 60000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BVM93X	(S)-2-Benzyloxycarbonylamino-3-{[3-(3-guanidino-propyl)-4,5-dihydro-isoxazole-5-carbonyl]-amino}-propionic acid	Investigative	44384863	C19H26N6O6	434.4	C1C(ON=C1CCCN=C(N)N)C(=O)NC[C@@H](C(=O)O)NC(=O)OCC2=CC=CC=C2	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BW0LZ6	(2S)-3-[[2-[(3R,5S)-1-(3,3-Dimethylbutanoyl)-5-[(pyridin-2-ylamino)methyl]pyrrolidin-3-yl]oxyacetyl]amino]-2-[(1-methylcyclohexanecarbonyl)amino]propanoic acid	Investigative	16756955	C29H45N5O6	559.7	CC1(CCCCC1)C(=O)N[C@@H](CNC(=O)CO[C@@H]2C[C@H](N(C2)C(=O)CC(C)(C)C)CNC3=CC=CC=N3)C(=O)O	IC50 ~ 50000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BW79JR	(5S,8S)-8-[(1H-Benzoimidazol-2-ylamino)-methyl]-3-[(S)-2-carboxy-2-(2,4,6-trimethyl-benzenesulfonylamino)-ethylcarbamoyl]-1-oxa-2,7-diaza-spiro[4.4]non-2-ene-7-carboxylic acid butyl ester	Investigative	44350415	C32H41N7O8S	683.8	CCCCOC(=O)N1C[C@]2(C[C@H]1CNC3=NC4=CC=CC=C4N3)CC(=NO2)C(=O)NC[C@@H](C(=O)O)NS(=O)(=O)C5=C(C=C(C=C5C)C)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BWBC86	1-[Methyl[4-(guanidinomethyl)benzoyl]aminoacetyl]piperidine-4-carboxylic acid	Investigative	44306715	C18H25N5O4	375.4	CN(CC(=O)N1CCC(CC1)C(=O)O)C(=O)C2=CC=C(C=C2)CN=C(N)N	IC50 = 52480.75 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BWHM58	(S)-2-Benzyloxycarbonylamino-3-{[3-(2-guanidino-ethyl)-4,5-dihydro-isoxazole-5-carbonyl]-amino}-propionic acid	Investigative	44383692	C18H24N6O6	420.4	C1C(ON=C1CCN=C(N)N)C(=O)NC[C@@H](C(=O)O)NC(=O)OCC2=CC=CC=C2	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BWQK69	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]-[(3,5-difluorophenyl)methyl]amino]acetate	Investigative	53380939	C29H32F2N4O4	538.6	CCOC(=O)CN(CC1=CC(=CC(=C1)F)F)C2=CC3=C(C=C2)N(CC(O3)(C)COC4=CC=C(C=C4)C(=N)N)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BWY19N	(S)-2-Benzyloxycarbonylamino-2-methyl-3-[4-(4-piperidin-4-yl-butoxy)-phenyl]-propionic acid	Investigative	10254067	C27H36N2O5	468.6	C[C@](CC1=CC=C(C=C1)OCCCCC2CCNCC2)(C(=O)O)NC(=O)OCC3=CC=CC=C3	IC50 = 65000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BX7YC9	6-[[(5-Amidino-1H-indol-2-yl)carbonyl]amino]hexanoic acid	Investigative	10335906	C16H20N4O3	316.35	C1=CC2=C(C=C1C(=N)N)C=C(N2)C(=O)NCCCCCC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BXT06B	3-({5-[3-(6-Amino-pyridin-2-yl)-propyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-2-(2,4,6-trimethyl-benzenesulfonylamino)-propionic acid	Investigative	11800065	C24H31N5O6S	517.6	CC1=CC(=C(C(=C1)C)S(=O)(=O)N[C@@H](CNC(=O)C2=NOC(C2)CCCC3=NC(=CC=C3)N)C(=O)O)C	IC50 = 78000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BYU97J	Ethyl 2-[[2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3H-1,4-benzoxazin-7-yl]-[(3,4-difluorophenyl)methyl]amino]-2-oxoacetate	Investigative	57392935	C29H30F2N4O5	552.6	CCOC(=O)C(=O)N(CC1=CC(=C(C=C1)F)F)C2=CC3=C(C=C2)N(CC(O3)(C)COC4=CC=C(C=C4)C(=N)N)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BZ4H6P	2-Benzyloxycarbonylamino-3-({5-[4-(pyridin-2-ylamino)-butyl]-4,5-dihydro-isoxazole-3-carbonyl}-amino)-propionic acid	Investigative	10648519	C24H29N5O6	483.5	C1C(ON=C1C(=O)NC[C@@H](C(=O)O)NC(=O)OCC2=CC=CC=C2)CCCCNC3=CC=CC=N3	IC50 = 85000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BZ59FA	2-[(4-Fluoro-2,6-dimethylbenzoyl)amino]-3-[4-[4-[(pyridin-2-ylamino)methyl]piperidin-1-yl]phenyl]propanoic acid	Investigative	24873345	C29H33FN4O3	504.6	CC1=CC(=CC(=C1C(=O)NC(CC2=CC=C(C=C2)N3CCC(CC3)CNC4=CC=CC=N4)C(=O)O)C)F	IC50 = 105000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BZ5J3H	8-[[(5-Amidino-1H-indol-2-yl)carbonyl]amino]octanoic acid	Investigative	11791726	C18H24N4O3	344.4	C1=CC2=C(C=C1C(=N)N)C=C(N2)C(=O)NCCCCCCCC(=O)O	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	BZMX79	(S)-2-(2,4,6-Trimethylphenylsulfonylamino)-3-[[5-[4-(sulfamoylamino)butyl]-2-isoxazolin-3-yl]carbonylamino]propionic acid	Investigative	10816131	C20H31N5O8S2	533.6	CC1=CC(=C(C(=C1)C)S(=O)(=O)N[C@@H](CNC(=O)C2=NOC(C2)CCCCNS(=O)(=O)N)C(=O)O)C	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	D06LKH	Gly-Arg-Gly-Asp-Ser	Investigative	123811	C17H30N8O9	490.5	C(C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)NC(=O)CN)CN=C(N)N	IC50 = 160000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	D0ID6U	CYCLORGDFV	Investigative	9851104	C26H38N8O7	574.6	CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N	IC50 ~ 100000 nM	Poor binder
T50688	Glycoprotein IIb/IIIa receptor	D0O5OM	VL-0395	Investigative	10742947	C26H23N5O4	469.5	C1=CC=C(C=C1)C(CC(=O)O)NC(=O)C2=CC(=CC=C2)NC(=O)C3=CC4=C(N3)C=CC(=C4)C(=N)N	IC50 = 50000 nM	Poor binder